DE2608259A1 - Verfahren zur herstellung von thyreotropin-freisetzendem hormon (trh) - Google Patents
Verfahren zur herstellung von thyreotropin-freisetzendem hormon (trh)Info
- Publication number
- DE2608259A1 DE2608259A1 DE19762608259 DE2608259A DE2608259A1 DE 2608259 A1 DE2608259 A1 DE 2608259A1 DE 19762608259 DE19762608259 DE 19762608259 DE 2608259 A DE2608259 A DE 2608259A DE 2608259 A1 DE2608259 A1 DE 2608259A1
- Authority
- DE
- Germany
- Prior art keywords
- trh
- ether
- dipeptide
- boc
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 17
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 102000011923 Thyrotropin Human genes 0.000 title description 2
- 108010061174 Thyrotropin Proteins 0.000 title description 2
- 239000003488 releasing hormone Substances 0.000 title description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- 108010016626 Dipeptides Proteins 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 125000006239 protecting group Chemical group 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 7
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 claims description 6
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 claims description 5
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 3
- XVQIEJCTJCUKMP-NSHDSACASA-N (2s)-2-[bis[(2-methylpropan-2-yl)oxycarbonyl]amino]-3-(1h-imidazol-5-yl)propanoic acid Chemical class CC(C)(C)OC(=O)N(C(=O)OC(C)(C)C)[C@H](C(O)=O)CC1=CNC=N1 XVQIEJCTJCUKMP-NSHDSACASA-N 0.000 claims description 2
- HYXIJPTUKBGWPV-VIFPVBQESA-N (2s)-2-(butoxycarbonylamino)-3-(1h-imidazol-5-yl)propanoic acid Chemical class CCCCOC(=O)N[C@H](C(O)=O)CC1=CN=CN1 HYXIJPTUKBGWPV-VIFPVBQESA-N 0.000 claims 1
- 230000029087 digestion Effects 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- 238000001226 reprecipitation Methods 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- -1 pyroglutamic acid ester Chemical class 0.000 description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 5
- AYMLQYFMYHISQO-QMMMGPOBSA-N (2s)-3-(1h-imidazol-3-ium-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate Chemical compound CC(C)(C)OC(=O)N[C@H](C(O)=O)CC1=CN=CN1 AYMLQYFMYHISQO-QMMMGPOBSA-N 0.000 description 4
- 101000721172 Homo sapiens Protein DBF4 homolog A Proteins 0.000 description 4
- 102100025198 Protein DBF4 homolog A Human genes 0.000 description 4
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102100032251 Pro-thyrotropin-releasing hormone Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 2
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229940034199 thyrotropin-releasing hormone Drugs 0.000 description 2
- ZKGMBAZWQLUSMW-VKHMYHEASA-N (2,3,4,5,6-pentachlorophenyl) (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1OC(=O)[C@H]1NC(=O)CC1 ZKGMBAZWQLUSMW-VKHMYHEASA-N 0.000 description 1
- NPWMTBZSRRLQNJ-VKHMYHEASA-N (3s)-3-aminopiperidine-2,6-dione Chemical group N[C@H]1CCC(=O)NC1=O NPWMTBZSRRLQNJ-VKHMYHEASA-N 0.000 description 1
- 125000003287 1H-imidazol-4-ylmethyl group Chemical group [H]N1C([H])=NC(C([H])([H])[*])=C1[H] 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- XXGKBUIZSICEDQ-SNVBAGLBSA-N ClC1(C([C@](N(C1=O)C1=CC=CC=C1)(C(=O)O)Cl)(Cl)Cl)Cl Chemical compound ClC1(C([C@](N(C1=O)C1=CC=CC=C1)(C(=O)O)Cl)(Cl)Cl)Cl XXGKBUIZSICEDQ-SNVBAGLBSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- BXRMEWOQUXOLDH-LURJTMIESA-N L-Histidine methyl ester Chemical compound COC(=O)[C@@H](N)CC1=CN=CN1 BXRMEWOQUXOLDH-LURJTMIESA-N 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 150000002308 glutamine derivatives Chemical class 0.000 description 1
- 238000006698 hydrazinolysis reaction Methods 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD18496975 | 1975-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2608259A1 true DE2608259A1 (de) | 1976-10-21 |
Family
ID=5499657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19762608259 Withdrawn DE2608259A1 (de) | 1975-03-24 | 1976-02-28 | Verfahren zur herstellung von thyreotropin-freisetzendem hormon (trh) |
Country Status (6)
| Country | Link |
|---|---|
| CH (1) | CH599926A5 (enExample) |
| CS (1) | CS190695B1 (enExample) |
| DE (1) | DE2608259A1 (enExample) |
| FR (1) | FR2305427A1 (enExample) |
| GB (1) | GB1497634A (enExample) |
| SU (1) | SU602496A1 (enExample) |
-
1976
- 1976-02-28 DE DE19762608259 patent/DE2608259A1/de not_active Withdrawn
- 1976-03-09 CS CS761537A patent/CS190695B1/cs unknown
- 1976-03-18 GB GB10910/76A patent/GB1497634A/en not_active Expired
- 1976-03-24 SU SU762336448A patent/SU602496A1/ru active
- 1976-03-24 CH CH366476A patent/CH599926A5/xx not_active IP Right Cessation
- 1976-03-24 FR FR7608494A patent/FR2305427A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CH599926A5 (enExample) | 1978-06-15 |
| SU602496A1 (ru) | 1978-04-15 |
| FR2305427B1 (enExample) | 1981-02-06 |
| CS190695B1 (en) | 1979-06-29 |
| GB1497634A (en) | 1978-01-12 |
| FR2305427A1 (fr) | 1976-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4009506A1 (de) | Hydantoinderivate | |
| CH650519A5 (de) | Auf das zentrale nervensystem wirkende tripeptide und verfahren zur herstellung derselben. | |
| EP0179332B1 (de) | Neue ZNS-aktive Peptide mit Wirkung auf das cholinerge System | |
| DE4123248A1 (de) | Verfahren zur herstellung von n-substituierten (alpha)-aminosaeuren und (alpha)-aminosaeure-derivaten | |
| EP0292729B1 (de) | Neue Festphasen-Peptidsynthesemethoden | |
| DE2731308A1 (de) | Psychopharmakologisch wirksame peptide und peptidderivate und verfahren zu deren herstellung | |
| DE2234798A1 (de) | 9-nieder-alkyl-9-fluorenyloxycarbonylderivate, verfahren zu ihrer herstellung und ihre verwendung als aminogruppenschutzreagentien bei der peptidsynthese | |
| DE3335865A1 (de) | Biologisch wirksame tri- und tetrapeptidalkylamide, ihre herstellung und pharmazeutische verwendung | |
| DE2460753A1 (de) | Verfahren zur herstellung von humaninsulin | |
| EP0278454B1 (de) | Pyridin-2,4- und 2,5-dicarbonsäure-Derivate, Verfahren zu ihrer Herstellung, Verwendung derselben sowie Arzneimittel auf Basis dieser Verbindungen | |
| DE2450357C2 (de) | Pentapeptid und Verfahren zu dessen Herstellung | |
| DE1935402A1 (de) | Neue sulfonierte Peptide | |
| DE69031623T2 (de) | Thioacylierungsmittel und zwischenprodukte, thiopeptide, und verfahren zu deren herstellung und anwendung | |
| EP0010587A1 (de) | Adamantylalkyloxycarbonylderivate, deren Herstellung und Verwendung zur Darstellung von Peptiden | |
| EP0048345B1 (de) | Verfahren zur Herstellung eines alpha-L-Aspartyl-L-Phenylalanin-Alkyl-Esters | |
| DE2608259A1 (de) | Verfahren zur herstellung von thyreotropin-freisetzendem hormon (trh) | |
| CH658661A5 (de) | Peptidverbindungen. | |
| DE68913618T2 (de) | Aminosäuren und Peptide mit einem modifizierten Tyrosin, ihre Herstellung und ihre Verwendung als Medikamente. | |
| DE2342862C3 (de) | An beiden Kettenenden Reste von a -Aminooxycarbonsäuren aufweisende Peptide mit ACTH-Wirkung, Verfahren zu ihrer Herstellung und diese Peptide enthaltende Arzneimittel | |
| US3749704A (en) | N-(omega-amino lower alkyl)-amides of 1,17-modified acth peptides | |
| EP0024664B1 (de) | Neue Peptidamide und Verfahren zu ihrer Herstellung | |
| DE1593858A1 (de) | Verfahren zur Herstellung tyrosinhaltiger Peptide und deren Derivaten | |
| DE3400746A1 (de) | Verfahren zur synthese von aspartam | |
| DE1205546B (de) | Verfahren zur Herstellung neuer Dekapeptide | |
| EP0279350B1 (de) | Annelierte Azepinon- und Azocinon-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung, sowie Zwischenprodukte bei ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |